Consequently, we have previously proposed that cFOS and TGFβ1 proteins may be considered as a pair of biomarkers of an early assessment of invasive BC [7, 8], providing adequate invasive BC specimens are available. The gene discussed is TGFB1; the disease is breast cancer.